{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:08Z","timestamp":1790393588172,"version":"4.1.0"},"reference-count":22,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Familial platelet disorder with associated myeloid malignancies (RUNX1-familial platelet disorder [RUNX1-FPD]) is caused by heterozygous pathogenic germline variants of RUNX1. In the present study, we evaluate the applicability of transactivation assays to investigate RUNX1 variants in different regions of the protein. We studied 11 variants to independently validate transactivation assays supporting variant classification following the ClinGen Myeloid Malignancies Variant Curation Expert Panel guidelines. Variant classification is key for the translation of genetic findings. We showed that new assays need to be developed to assess C-terminal RUNX1 variants. Two variants of uncertain significance (VUS) were reclassified to likely pathogenic. Additionally, our analyses supported the (likely) pathogenic classification of 2 other variants. We demonstrated functionality of 4 VUS, but reclassification to (likely) benign was challenging and suggested the need for reevaluating current classification guidelines. Finally, clinical utility of our assays was illustrated in the context of 7 families. Our data confirmed RUNX1-FPD suspicion in 3 families with RUNX1-FPD-specific family history, whereas for 3 variants identified in RUNX1-FPD-nonspecific families, no functional defect was detected. Applying functional assays to support RUNX1 variant classification can be essential for adequate care of index patients and their relatives at risk. It facilitates translation of genetic data into personalized medicine.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006161","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T22:05:27Z","timestamp":1642111527000},"page":"3195-3200","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Validation and clinical application of transactivation assays for<i>RUNX1<\/i>variant classification"],"prefix":"10.1182","volume":"6","author":[{"given":"Melanie","family":"Decker","sequence":"first","affiliation":[{"name":"1Department of Human Genetics, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"Agarwal","sequence":"additional","affiliation":[{"name":"2Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Benneche","sequence":"additional","affiliation":[{"name":"3Western Norway Familial Cancer Center, Haukeland University Hospital, Bergen, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Churpek","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Section of Hematology, Oncology, and Palliative Care, The University of Wisconsin-Madison, Madison, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-1022","authenticated-orcid":false,"given":"Nicolas","family":"Duployez","sequence":"additional","affiliation":[{"name":"5Department of Hematology, CHU Lille, University Lille, INSERM U1277, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Duvall","sequence":"additional","affiliation":[{"name":"6The University of Chicago Medicine, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn P. T.","family":"Ernst","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-8483","authenticated-orcid":false,"given":"Alisa","family":"F\u00f6rster","sequence":"additional","affiliation":[{"name":"1Department of Human Genetics, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-576X","authenticated-orcid":false,"given":"Hildegunn","family":"H\u00f8berg-Vetti","sequence":"additional","affiliation":[{"name":"3Western Norway Familial Cancer Center, Haukeland University Hospital, Bergen, Norway;"},{"name":"8Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547, ERN GENTURIS coordinating office, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Hofmann","sequence":"additional","affiliation":[{"name":"9Department of Pediatrics, Division of Pediatric Hematology\/Oncology and BMT, University of Wisconsin, Madison, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Nash","sequence":"additional","affiliation":[{"name":"10Division of Hematology\/Oncology and Cellular Therapy, Cohen Children's Medical Center, Northwell Health, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H. G. P.","family":"Raaijmakers","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor H. A.","family":"Tvedt","sequence":"additional","affiliation":[{"name":"11Department of Medicine, Haukeland University Hospital, Bergen, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4068-5406","authenticated-orcid":false,"given":"Adrianna","family":"Vlachos","sequence":"additional","affiliation":[{"name":"10Division of Hematology\/Oncology and Cellular Therapy, Cohen Children's Medical Center, Northwell Health, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-1270","authenticated-orcid":false,"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[{"name":"1Department of Human Genetics, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4284-5389","authenticated-orcid":false,"given":"Thomas","family":"Illig","sequence":"additional","affiliation":[{"name":"1Department of Human Genetics, Hannover Medical School, Hannover, Germany;"},{"name":"12Hannover Unified Biobank, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-8612","authenticated-orcid":false,"given":"Tim","family":"Ripperger","sequence":"additional","affiliation":[{"name":"1Department of Human Genetics, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"issue":"2","key":"2022052715235121500_B1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet."},{"issue":"2","key":"2022052715235121500_B2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.seminhematol.2017.04.006","article-title":"RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)","volume":"54","author":"Schlegelberger","year":"2017","journal-title":"Semin Hematol."},{"issue":"6","key":"2022052715235121500_B3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv."},{"issue":"1","key":"2022052715235121500_B4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood."},{"issue":"5","key":"2022052715235121500_B5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jth.12550","article-title":"Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets","volume":"12","author":"Glembotsky","year":"2014","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2022052715235121500_B6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/hae.13280","article-title":"Defective acid hydrolase secretion in RUNX1 haplodeficiency: evidence for a global platelet secretory defect","volume":"23","author":"Rao","year":"2017","journal-title":"Haemophilia."},{"issue":"1","key":"2022052715235121500_B7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard","year":"2016","journal-title":"Orphanet J Rare Dis."},{"issue":"20","key":"2022052715235121500_B8","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","article-title":"ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants","volume":"3","author":"Luo","year":"2019","journal-title":"Blood Adv."},{"issue":"5","key":"2022052715235121500_B9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"issue":"11","key":"2022052715235121500_B10","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1038\/s41375-021-01200-w","article-title":"Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies","volume":"35","author":"Decker","year":"2021","journal-title":"Leukemia."},{"issue":"1","key":"2022052715235121500_B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med."},{"issue":"11","key":"2022052715235121500_B12","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.3324\/haematol.2021.278762","article-title":"The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy","volume":"106","author":"Homan","year":"2021","journal-title":"Haematologica."},{"issue":"10","key":"2022052715235121500_B13","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.2020008478","article-title":"RUNX1 germline variants in RUNX1-mutant AML: how frequent?","volume":"137","author":"Ernst","year":"2021","journal-title":"Blood."},{"key":"2022052715235121500_B14","volume-title":"GeneReviews(\u00ae). Vol. updated 2021 May 6.","author":"Deuitch","year":"2021"},{"key":"2022052715235121500_B15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fped.2017.00252","article-title":"Clinical assessment and diagnosis of germline predisposition to hematopoietic malignancies: the University of Chicago experience","volume":"5","author":"Desai","year":"2017","journal-title":"Front Pediatr."},{"issue":"12","key":"2022052715235121500_B16","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood."},{"issue":"4","key":"2022052715235121500_B17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.236","article-title":"Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia","volume":"30","author":"Antony-Debr\u00e9","year":"2016","journal-title":"Leukemia."},{"issue":"7","key":"2022052715235121500_B18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood."},{"issue":"21","key":"2022052715235121500_B19","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.2019003357","article-title":"High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML","volume":"135","author":"Simon","year":"2020","journal-title":"Blood."},{"issue":"20","key":"2022052715235121500_B20","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1093\/hmg\/ddab141","article-title":"Germline predisposition to hematopoietic malignancies","volume":"30","author":"Feurstein","year":"2021","journal-title":"Hum Mol Genet."},{"issue":"1","key":"2022052715235121500_B21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2741\/3977","article-title":"RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis","volume":"17","author":"Lam","year":"2012","journal-title":"Front Biosci."},{"issue":"9","key":"2022052715235121500_B22","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/leu.2013.200","article-title":"RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes","volume":"27","author":"Koh","year":"2013","journal-title":"Leukemia."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3195\/1898776\/advancesadv2021006161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3195\/1898776\/advancesadv2021006161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T22:16:26Z","timestamp":1674425786000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/11\/3195\/483518\/Validation-and-clinical-application-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,6,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006161","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}